Table 1.
Classification frequencies of comorbidity risks for Black and white Alabamians with COPD, BRFSS, 2015–2019.
| Comorbidities | White | Black | ||||
|---|---|---|---|---|---|---|
| Asthma | Yes n (%) |
No n (%) |
p-value | Yes n (%) |
No n (%) |
p-value |
| Low Risk | 368 (27.88) | 952 (72.12) | <0.0001 | 133 (30.09) | 309 (69.91) | <0.0001 |
| Intermediate Risk | 41 (10.85) | 337 (89.15) | 255 (63.91) | 144 (36.09) | ||
| High Risk | 775 (63.27) | 450 (36.73) | 7 (25.00) | 21 (75) | ||
| Diabetes | Yes n (%) |
No n (%) |
p-value | Yes n (%) |
No n (%) |
p-value |
| Low Risk | 0 (0.00) | 1324 (100) | <0.0001 | 60 (13.61) | 381 (86.39) | <0.0001 |
| Intermediate Risk | 286 (75.46) | 93 (24.54) | 217 (55.08) | 177 (44.92) | ||
| High Risk | 519 (42.51) | 702 (57.49) | 14 (51.85) | 13 (48.15) | ||
| Obesity | Yes n (%) |
No n (%) |
p-value | Yes n (%) |
No n (%) |
p-value |
| Low Risk | 224 (17.72) | 1040 (82.28) | <0.0001 | 133 (32.44) | 277 (67.56) | <0.0001 |
| Intermediate Risk | 166 (45.60) | 198 (54.40) | 301 (80.48) | 73 (19.52) | ||
| High Risk | 678 (57.56) | 500 (42.44) | 2 (7.69) | 24 (92.31) | ||
| Cardiovascular Disease (CVD) | Yes n (%) |
No n (%) |
p-value | Yes n (%) |
No n (%) |
p-value |
| Low Risk | 68 (5.23) | 1233 (94.77) | <0.0001 | 20 (4.59) | 416 (95.41) | <0.0001 |
| Intermediate Risk | 148 (39.57) | 226 (60.43) | 103 (26.21) | 290 (73.79) | ||
| High Risk | 423 (35.67) | 763 (64.33) | 23 (82.14) | 5 (17.86) | ||
| Arthritis | Yes n (%) |
No n (%) |
p-value | Yes n (%) |
No n (%) |
p-value |
| Low Risk | 704 (53.09) | 622 (46.91) | <0.0001 | 181 (41.42) | 256 (58.58) | <0.0001 |
| Intermediate Risk | 168 (44.09) | 213 (55.91) | 376 (94.24) | 23 (5.76) | ||
| High Risk | 1192 (97.47) | 31 (2.53) | 24 (85.71) | 4 (14.29) | ||
| Stroke | Yes n (%) |
No n (%) |
p-value | Yes n (%) |
No n (%) |
p-value |
| Low Risk | 66 (4.97) | 1261 (95.03) | <0.0001 | 25 (5.64) | 418 (94.36) | <0.0001 |
| Intermediate Risk | 29 (7.69) | 348 (92.31) | 86 (21.50) | 314 (78.50) | ||
| High Risk | 345 (28.21) | 878 (71.79) | 15 (53.57) | 13 (46.43) | ||
| Depressive Disorder | Yes n (%) |
No n (%) |
p-value | Yes n (%) |
No n (%) |
p-value |
| Low Risk | 413 (31.24) | 909 (68.76) | <0.0001 | 97 (22.25) | 339 (77.75) | <0.0001 |
| Intermediate Risk | 42 (11.02) | 339 (88.98) | 232 (58.00) | 168 (42.00) | ||
| High Risk | 855 (70.31) | 361 (29.69) | 16 (57.14) | 12 (42.86) | ||
| Chronic Kidney Disease | Yes n (%) |
No n (%) |
p-value | Yes n (%) |
No n (%) |
p-value |
| Low Risk | 16 (1.20) | 1313 (98.80) | <0.0001 | 10 (2.26) | 432 (97.74) | <0.0001 |
| Intermediate Risk | 41 (10.88) | 336 (89.12) | 43 (10.72) | 358 (89.28) | ||
| High Risk | 214 (17.60) | 1002 (82.40) | 28 (100.00) | 0 (0.00) | ||